IL13 and neoplasm: Conversely, M2-like TAMs are driven by IL-4, IL-13, and IL-10, and promote tumor progression by releasing immunosuppressive factors (PGE2, TGF-β, IL-10), and pro-angiogenic mediators (FGF, PDGF, VEGF) (14).